{"id":621921,"title":"Notice: Prescription Drug List (PDL): Hyoscine butylbromide - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-26","captureTimestamp":"2026-02-26T01:19:19.575000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-hyoscine-butylbromide-1.html","snippet":"Notice: Prescription Drug List (PDL): Hyoscine butylbromide August 26, 2016 Our file number: 16-109536-761 The purpose of this Notice of Amendment is to notify that Health Canada will switch injectable Hyoscine butylbromide to prescription status from ethical status for human use…","rawSnapshotUrl":"/api/snapshots/raw/621921","browseUrl":"https://replay.healtharchive.ca/job-6/20260226011919/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-hyoscine-butylbromide-1.html#ha_snapshot=621921","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}